AVB vs AVBP · P/E 23, rev $3.04B vs $1.39B cap
AvalonBay Communities Inc (AVB) versus ArriVent BioPharma, Inc. Common Stock (AVBP) — a side-by-side from cached financials, not a winner call.
AvalonBay Communities Inc (AVB) is a reit - residential company listed on US.
ArriVent BioPharma, Inc. Common Stock (AVBP) is a biotechnology company listed on US.
Latest reported AVB revenue for 2025-12-31 was $3.04B. Net income was $1.06B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. AVB currently screens at market cap $26.84B and trailing P/E 23.4.
AVBP does not have a complete income-statement cache yet.
AVB currently screens at market cap $26.84B and trailing P/E 23.4. AVBP currently screens at market cap $1.39B.
Not investment advice. Open the AVB and AVBP stock pages for the full models.
Not investment advice.